Vincent Milano insider trades
Open-market stock purchases and sales by Vincent Milano, Director at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Jan 7, 2010.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +22%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $11.2K |
| Jun 11, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 11, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 5, 2026 | ACRS Aclaris Therapeutics, Inc | Bought (not open market) | — |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc | Bought (not open market) | — |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc | Bought (not open market) | — |
| May 29, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $10K |
| Feb 27, 2026 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $7.4K |
| Nov 28, 2025 | BCRX Biocryst Pharmaceuticals Inc | Bought (not open market) | $5.6K |
Companies traded
- BCRX Biocryst Pharmaceuticals Inc: 2 buys, last Aug 31, 2026
- ACRS Aclaris Therapeutics, Inc: other filings, last Jun 5, 2026
- ACGN Aceragen, Inc: 1 sale, last Aug 10, 2023
- IDRA Idera Pharmaceuticals, Inc: 4 buys, 5 sales, last Jul 6, 2022
- ONCE Spark Therapeutics, Inc: other filings, last Dec 17, 2019
- VNDA Vanda Pharmaceuticals Inc: other filings, last Jun 13, 2018
- VPHM Viropharma Inc: 5 sales, last Jan 24, 2014